A randomized comparison between early and late vaccination with tetanus toxoid vaccine after allogeneic BMT

Bone Marrow Transplantation

Volumn 19, Issue 9, 1997, Pages 933-938

  Parkkali, T ^a   Olander R M ^b   Ruutu, T ^a   Vuontela, K ^b   Volin, L ^a   Eskola, J ^b   Ruutu, P ^b  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

BMT recipients; Tetanus vaccination; Vaccination response

Indexed keywords

HAEMOPHILUS INFLUENZAE TYPE B VACCINE; MENINGOCOCCUS VACCINE; PNEUMOCOCCUS VACCINE; POLIO NOVUM; POLIOMYELITIS VACCINE; TETANUS ANTIBODY; TETANUS TOXOID; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ANTIBODY RESPONSE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TETANUS; TETANUS PROPHYLAXIS;

EID: 0030989178     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1700768     Document Type: Article

References (24)

1. Lum LG. Immune recovery after bone marrow transplantation. Hematol Oncol Clin North Am 1990; 4: 659-675.
2. Storek J, Saxon A. Reconstitution of B cell immunity following bone marrow transplantation. Bone Marrow Transplant 1992; 9: 395-408.
3. Lum LG, Munn NA, Schanfield MS, Storb R. The detection of specific antibody formation to recall antigens after human bone marrow transplantation. Blood 1986; 67: 582-587.
4. Lum LG, Noges JE, Beatty P et al. Transfer of specific immunity in marrow recipients given HLA-mismatched. T cell-depleted, or HLA-identical marrow grafts. Bone Marrow Transplant 1988; 3: 399-406.
5. Ljungman P, Wiklund-Hammarsten M, Duraj V et al. Response to tetanus toxoid immunization after allogeneic bone marrow transplantation. J Infect Dis 1990; 162: 496-500.
6. Li Volti S, Mauro L, Di Gregorio F et al. Immune status and immune response to diphtheria-tetanus and polio vaccines in allogeneic bone marrow-transplanted thalassemic patients. Bone Marrow Transplant 1994; 14: 225-227.
7. Ljungman P, Cordonnier C, de Bock R et al. Immunisations after bone marrow transplantation: results of a European survey and recommendations from the infectious diseases working party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 1995; 15: 455-460.
8. Wassilak SGF, Orenstein WA, Sutter RW. Tetanus toxoid. In: Plotkin SA, Mortimer EA Jr (eds). Vaccines. WB Saunders: Philadelphia, 1994, pp 57-90.
9. Thomas ED, Storb R, Clift RA et al. Bone marrow transplantation. New Engl J Med 1975; 292: 895-902.
10. Shulman HM, Sullivan KM, Weiden PL et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980; 69: 204-217.
11. Peel MM. Measurement of tetanus antitoxin I. Indirect haemagglutination. J Biol Stand 1980; 8: 177-189.
12. Gentili G, Pini C, Collotti C. The use of an immunoenzymatic assay for the estimation of tetanus antitoxin in human sera: a comparison with seroneutralization and indirect haemagglutination. J Biol Stand 1985; 13: 53-59.
13. Simonsen O, Badsberg JH, Kjeldsen K et al. The fall-off in serum concentration of tetanus antitoxin after primary and booster vaccination. APMIS 1986; 94: 77-82.
14. Mackall CL, Fleisher TA, Brown MR et al. Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy. New Engl J Med 1995; 332: 143-149.
15. Guinan EC, Molrine DC, Antin JH et al. Polysaccharide conjugate vaccine responses in bone marrow transplant patients. Transplantation 1994; 57: 677-684.
16. Alanko S, Pelliniemi T-T, Uksila J et al. Responses to tetanus and diphtheria toxoid, and poliovirus vaccines after cessation of therapy for cancer (submitted).
17. Ljungman P, Fridell E, Lönnqvist B et al. Efficacy and safety of vaccination of marrow transplant recipients with a live attenuated measles, mumps, and rubella vaccine. J Infect Dis 1989; 159: 610-615.
18. Ljungman P, Duraj V, Magnius L. Response to immunization against polio after allogeneic marrow transplantation. Bone Marrow Transplant 1991; 7: 89-93.
19. Saxon A, Mitsuyasu R, Stevens R et al. Designed transfer of specific immune responses with bone marrow transplantation. J Clin Invest 1986; 78: 959-967.
20. Wimperis JZ, Brenner MK, Prentice HG et al. B cell development and regulation after T cell-depleted marrow transplantation. J Immunol 1987; 138: 2445-2450.
21. Wahren B, Gahrton G, Linde A et al. Transfer and persistence of viral antibody-producing cells in bone marrow transplantation. J Infect Dis 1984; 150: 358-365.
22. Wimperis JZ, Brenner MK, Prentice HG et al. Transfer of a functioning humoral immune system in transplantation of T-lymphocyte-depleted bone marrow. Lancet 1986; 1: 339-343.
23. MacLennan R, Schofield FD, Pittman M et al. Immunization against neonatal tetanus in New Guinea. Bull WHO 1965; 32: 683-697.
24. Myers MG, Beckman CW, Vosdingh RA, Hankins WA. Primary immunization with tetanus and diphtheria toxoids. Reaction rates and immunogenicity in older children and adults. JAMA 1982; 248: 2478-2480.